Senores Pharma.

{
  "main_header": {
    "sid": 10039497,
    "name": "Senores Pharma.",
    "stock_name": "Senores Pharma.",
    "full_name": "Senores Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/senores-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,111.95",
    "chg": 18.2,
    "chgp": "1.66%",
    "dir": 1,
    "prev_price": "1,093.75",
    "mcapval": "5,189.00 Cr",
    "mcap": "Small Cap",
    "scripcode": "544319",
    "symbol": "SENORES",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE0RB801010",
    "curr_date": "Jun 10, 03:30 PM",
    "curr_time": "02:34 AM",
    "last_traded_at": "Jun 10, 03:30 PM IST",
    "bse_nse_vol": "5.22 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 10, 2026",
    "traded_date_str": "2026 06 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/senores-pharma-10039497-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Senores Pharmaceuticals Ltd Surges 7.77% to Day's High of Rs 1064.4 — Outperforms Sector by 4.87 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-hits-intraday-high-with-777-surge-on-9-june-2026-4041177",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SenoresPharmace_priceRelatedfactors_4041177.png",
        "date": "2026-06-09 12:31:34",
        "description": "The Sensex edged up 0.32% on 09 Jun 2026, while Senores Pharmaceuticals Ltd surged 7.77%, outperforming its sector by nearly 5 percentage points. This sharp single-session gain rewrites the short-term narrative for the small-cap pharmaceutical player, raising the question of whether this is a genuine breakout or a technical bounce within a broader trend."
      },
      {
        "title": "Senores Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/senores-pharmaceuticals-ltd-is-rated-hold-4033469",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SenoresPharmace_mojoScore_4033469.png",
        "date": "2026-06-03 10:11:05",
        "description": "Senores Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 03 June 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Senores Pharmaceuticals Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-sees-technical-momentum-shift-amid-mixed-indicator-signals-4029954",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SenoresPharmace_technicaldot_4029954.png",
        "date": "2026-06-02 08:11:43",
        "description": "Senores Pharmaceuticals Ltd has experienced a notable shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals. Despite a recent decline in price, the stock’s momentum indicators reveal a nuanced outlook, prompting a reassessment of its medium-term prospects within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Senores Pharmaceuticals Ltd Opens 5.19% Lower in Sharp Gap Down as Technicals Point to Mixed Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-opens-with-significant-gap-down-amid-market-concerns-4025719",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SenoresPharmace_gapdown_4025719.png",
        "date": "2026-06-01 09:31:56",
        "description": ""
      },
      {
        "title": "Senores Pharmaceuticals Ltd Valuation Shifts Signal Heightened Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-valuation-shifts-signal-heightened-price-attractiveness-4012541",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SenoresPharmace_valuationdot_4012541.png",
        "date": "2026-05-26 08:02:36",
        "description": "Senores Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive rating, reflecting evolving market perceptions and price attractiveness. This article analyses the recent changes in key valuation metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, comparing them with historical trends and peer benchmarks to provide a comprehensive view of the stock’s current standing."
      },
      {
        "title": "Senores Pharmaceuticals Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/senores-pharmaceuticals-ltd-is-rated-buy-4007992",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SenoresPharmace_mojoScore_4007992.png",
        "date": "2026-05-23 10:10:05",
        "description": "Senores Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 08 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 May 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Senores Pharmaceuticals Gains 5.52%: 4 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-gains-552-4-key-factors-driving-the-weeks-momentum-4007677",
        "imagepath": "",
        "date": "2026-05-23 10:00:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>18 May:</strong> New 52-week and all-time highs reached (Rs.1,130.05)</p>\n                    <p><strong>19 May:</strong> Valuation shifts to very expensive amid strong price surge</p>\n                    <p><strong>20 May:</strong> Moderate recovery after correction (Rs.1,082.95)</p>\n                    <p><strong>21 May:</strong> Continued gains supported by technical strength (Rs.1,107.70)</p>\n                    <p><strong>22 May:</strong> Week closes near highs at Rs.1,110.45 (+0.25%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,052.35</div></d..."
      },
      {
        "title": "Senores Pharmaceuticals Ltd Valuation Shifts Amid Strong Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-valuation-shifts-amid-strong-market-performance-3997953",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SenoresPharmace_valuationdot_3997953.png",
        "date": "2026-05-19 08:03:11",
        "description": "Senores Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive classification, despite robust stock price gains and strong operational metrics. This article analyses the evolving price attractiveness of the small-cap pharmaceutical player in the context of its peer group and historical benchmarks."
      },
      {
        "title": "Senores Pharmaceuticals Ltd Surges 7.87% to Day's High of Rs 1130 — Outperforms Sector by 8.06 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-hits-intraday-high-with-strong-787-surge-3996950",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SenoresPharmace_priceRelatedfactors_3996950.png",
        "date": "2026-05-18 11:01:09",
        "description": "While the Sensex retreated 0.76% on 18 May 2026, Senores Pharmaceuticals Ltd surged 7.87%, touching a fresh 52-week and all-time high of Rs 1130. This 8.06 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a market-wide uplift."
      }
    ],
    "total": 242,
    "sid": "10039497",
    "stock_news_url": "https://www.marketsmojo.com/news/senores-pharmaceuticals-10039497"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "04-Jun-2026",
      "details": "Senores Pharmaceuticals Limited has informed the Exchange regarding Analyst/Institutional Investor meet scheduled to be held on June 09 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "22-May-2026",
      "details": "Senores Pharmaceuticals Limited has informed the Exchange regarding Analyst/Institutional Investor meet scheduled to be held on May 28 2026.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "21-May-2026",
      "details": "Senores Pharmaceuticals Limited has informed the Exchange regarding submission of Annual Secretarial Compliance Report for financial year ended March 31 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Senores Pharmaceuticals Ltd Surges 7.77% to Day's High of Rs 1064.4 — Outperforms Sector by 4.87 Percentage Points

2026-06-09 12:31:34

The Sensex edged up 0.32% on 09 Jun 2026, while Senores Pharmaceuticals Ltd surged 7.77%, outperforming its sector by nearly 5 percentage points. This sharp single-session gain rewrites the short-term narrative for the small-cap pharmaceutical player, raising the question of whether this is a genuine breakout or a technical bounce within a broader trend.

Read full news article

Senores Pharmaceuticals Ltd is Rated Hold

2026-06-03 10:11:05

Senores Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 03 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Senores Pharmaceuticals Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals

2026-06-02 08:11:43

Senores Pharmaceuticals Ltd has experienced a notable shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals. Despite a recent decline in price, the stock’s momentum indicators reveal a nuanced outlook, prompting a reassessment of its medium-term prospects within the Pharmaceuticals & Biotechnology sector.

Read full news article

Senores Pharmaceuticals Ltd Opens 5.19% Lower in Sharp Gap Down as Technicals Point to Mixed Signals

2026-06-01 09:31:56

Read full news article

Senores Pharmaceuticals Ltd Valuation Shifts Signal Heightened Price Attractiveness

2026-05-26 08:02:36

Senores Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive rating, reflecting evolving market perceptions and price attractiveness. This article analyses the recent changes in key valuation metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, comparing them with historical trends and peer benchmarks to provide a comprehensive view of the stock’s current standing.

Read full news article

Senores Pharmaceuticals Ltd is Rated Buy

2026-05-23 10:10:05

Senores Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 08 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Senores Pharmaceuticals Gains 5.52%: 4 Key Factors Driving the Week’s Momentum

2026-05-23 10:00:05

Key Events This Week

18 May: New 52-week and all-time highs reached (Rs.1,130.05)

19 May: Valuation shifts to very expensive amid strong price surge

20 May: Moderate recovery after correction (Rs.1,082.95)

21 May: Continued gains supported by technical strength (Rs.1,107.70)

22 May: Week closes near highs at Rs.1,110.45 (+0.25%)

Week Open

Rs.1,052.35

Read full news article

Senores Pharmaceuticals Ltd Valuation Shifts Amid Strong Market Performance

2026-05-19 08:03:11

Senores Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive classification, despite robust stock price gains and strong operational metrics. This article analyses the evolving price attractiveness of the small-cap pharmaceutical player in the context of its peer group and historical benchmarks.

Read full news article

Senores Pharmaceuticals Ltd Surges 7.87% to Day's High of Rs 1130 — Outperforms Sector by 8.06 Percentage Points

2026-05-18 11:01:09

While the Sensex retreated 0.76% on 18 May 2026, Senores Pharmaceuticals Ltd surged 7.87%, touching a fresh 52-week and all-time high of Rs 1130. This 8.06 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a market-wide uplift.

Read full news article

View All News